Matches in Wikidata for { <http://www.wikidata.org/entity/Q91221332> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91221332 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91221332 description "scientific article published on 02 December 2019" @default.
- Q91221332 description "wetenschappelijk artikel" @default.
- Q91221332 description "наукова стаття, опублікована 2 грудня 2019" @default.
- Q91221332 name "The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia" @default.
- Q91221332 name "The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia" @default.
- Q91221332 type Item @default.
- Q91221332 label "The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia" @default.
- Q91221332 label "The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia" @default.
- Q91221332 prefLabel "The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia" @default.
- Q91221332 prefLabel "The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia" @default.
- Q91221332 P1433 Q91221332-F4C58D49-306E-4499-9D6B-49D5F6B49317 @default.
- Q91221332 P1476 Q91221332-B37497BC-52C9-4AA0-8D7D-B03BCBE35EF6 @default.
- Q91221332 P2093 Q91221332-12275024-B435-4A5D-BD7F-D206F4C9F0B7 @default.
- Q91221332 P2093 Q91221332-9B84DBEE-FAB2-418F-AE0A-AD646785F2BF @default.
- Q91221332 P2093 Q91221332-DF922787-ECD7-4E30-BBAC-771439865EE1 @default.
- Q91221332 P304 Q91221332-638E42DA-D5FB-48D6-820A-64901363BFE7 @default.
- Q91221332 P31 Q91221332-EBC35C21-8CB9-460A-AF6A-88C7C03AD846 @default.
- Q91221332 P356 Q91221332-399AFBF3-F0D4-4A26-A556-EF44423B8B70 @default.
- Q91221332 P433 Q91221332-D8A07220-C58B-44F1-A5F2-BC834B0BE5F5 @default.
- Q91221332 P478 Q91221332-07D38B0F-143C-4E86-A7AC-F234FD79A628 @default.
- Q91221332 P577 Q91221332-E76BB9D4-F064-4174-B420-056E7BD8E9B5 @default.
- Q91221332 P698 Q91221332-AB222BA3-737E-4DDD-950D-7AEE7A85E507 @default.
- Q91221332 P921 Q91221332-13B0816B-D659-400A-B3DB-89C0C01AC3AA @default.
- Q91221332 P921 Q91221332-8A2435C2-05CB-49EF-A1E8-8EA7422F7033 @default.
- Q91221332 P356 AJH.25676 @default.
- Q91221332 P698 31709578 @default.
- Q91221332 P1433 Q4744246 @default.
- Q91221332 P1476 "The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia" @default.
- Q91221332 P2093 "Amrit P Singh" @default.
- Q91221332 P2093 "Carolina Schinke" @default.
- Q91221332 P2093 "Sos Nalghranyan" @default.
- Q91221332 P304 "E34-E35" @default.
- Q91221332 P31 Q13442814 @default.
- Q91221332 P356 "10.1002/AJH.25676" @default.
- Q91221332 P433 "2" @default.
- Q91221332 P478 "95" @default.
- Q91221332 P577 "2019-12-02T00:00:00Z" @default.
- Q91221332 P698 "31709578" @default.
- Q91221332 P921 Q422252 @default.
- Q91221332 P921 Q7201765 @default.